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Abstract: Bio-artificial polymeric systems are a new class of polymeric constituents based on blends
of synthetic and natural polymers, designed with the purpose of producing new materials that exhibit
enhanced properties with respect to the individual components. In this frame, a combination of
polyvinyl alcohol (PVA) and chitosan, blended with a widely used antibiotic, sodium ampicillin,
has been developed showing a moderate behavior in terms of antibacterial properties. Thus,
aqueous solutions of PVA at 1 wt.% were mixed with acid solutions of chitosan at 1 wt.%, followed
by adding ampicillin ranging from 0.3 to 1.0 wt.% related to the total amount of the polymers.
The prepared bio-artificial polymeric system was characterized by FTIR, SEM, DSC, contact angle
measurements, antibacterial activity against Staphylococcus aureus and Escherichia coli and antibiotic
release studies. The statistical significance of the antibacterial activity was determined using a
multifactorial analysis of variance with ρ < 0.05 (ANOVA). The characterization techniques did
not show alterations in the ampicillin structure and the interactions with polymers were limited
to intermolecular forces. Therefore, the antibiotic was efficiently released from the matrix and its
antibacterial activity was preserved. The system disclosed moderate antibacterial activity against
bacterial strains without adding a high antibiotic concentration. The findings of this study suggest
that the system may be effective against healthcare-associated infections, a promising view in the
design of novel antimicrobial biomaterials potentially suitable for tissue engineering applications.
Keywords: bio-artificial polymeric system; health-care associated infections; polyvinyl alcohol;
chitosan; ampicillin
1. Introduction
Copious literature has evidenced the extraordinary applicability of polymers in medical
fields [1–10]. In fact, these materials are used in tissue engineering, implantation of medical
devices, artificial organs, prostheses, ophthalmology, dentistry, and bone repairing [7]. Nevertheless,
natural polymers do not have appropriate mechanical properties whereas synthetics are deficient in
terms of biocompatibility. In this matter, their combination has gathered growing interest from the
scientific community in the recent past. Most of these systems, called bioartificial polymeric systems
(BAPS), have attracting characteristics for biomedical applications, and were originally conceived
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with the aim of combining the features of synthetic polymers (good mechanical properties, easy
processability, low production and transformation costs) with the specific tissue- and cel- compatibility
of biopolymers [11,12].
The BAPS may be produced as hydrogels, films, scaffolds, and a great variety of potential
applications has been reported including dialysis membranes, artificial skin, cardiovascular devices,
implants, bandages, or even controlled drug-release systems [13–15]. In spite of the remarkable
potential that the BAPS have revealed, they lack inherent attributes such as bactericidal or bacteriostatic
properties, whereby the BAPS in the medical field might be focused on the appeasement of
healthcare-associated infections which boosts health systems costs. As an approach for facing bacteria
colonization, controlled released drug systems from polymeric matrixes might be catalogued as an
auspicious solution [16,17].
One of the methods for reducing or preventing infections is the development of polymer-antibiotic
systems [17]. BAPS might be included in this category because of the individual properties of both
natural and synthetic components, as well as the interaction that might occur among them. In that
respect, chitosan (CHI) as a natural polymer has been investigated and its antimicrobial properties
against a wide range of target microorganisms (algae, bacteria, yeasts and fungi) have been reported
in experiments involving in vivo and in vitro studies, and in different forms (solutions, films, and
composites). Nonetheless, recent data in the literature have the tendency to characterize chitosan
as bacteriostatic rather than bactericidal. This polymer has been extensively used in biomedical
applications, as material for chemicals encapsulation and controlled release [18,19]. CHI is widely-used
as an antimicrobial agent either alone or blended with other natural polymers (starch, gelatin,
alginates), in food, pharmaceutical, textile, agriculture, water treatment, and cosmetics industries [20].
Furthermore, it is hydrophilic; hence, CHI films are poor barriers to moisture. For these reasons,
some biodegradable synthetic polymers, such as poly (caprolactone), poly (lactic acid), and poly
(vinyl alcohol) (PVA) were used to modify strength, water resistance, and thermal stability of CHI
films [21–24].
As a synthetic polymer, PVA has centered the interest from scientists in diverse areas such as
engineering, chemistry and medicine. In medical uses, properties such as a high capability of water
absorption, chemical resistance, physical properties, biocompatibility, and complete biodegradability
are responsible for its relevant uses. PVA has indeed unique features including excellent film-forming
properties and is non-toxic, as well as its significance as a part of controlled drug delivery systems,
dialysis membrane, wound dressing, artificial cartilage, and tissue engineering scaffold [25–27].
The combination of CHI and PVA may have beneficial effects on the biological characteristics of the
blend. In fact, it has been reported that the chemical crosslinking between CHI and PVA may improve
the mechanical strength and thermal stability, keeping the intrinsic properties of transparency and the
swelling ability of CHI films [28,29]. Indeed, the use of plasticizers and crosslinkers imparts specific
properties in the system and therefore, their mechanical drawbacks are diminished or attenuated.
On the other hand, it is generally assumed that the polycationic nature of CHI, conveyed by
the positively charged -NH3+ groups of glucosamine, might be a fundamental factor contributing
to its interaction with negatively charged surface components of many fungi and bacteria, causing
substantial cell surface alterations, leakage of intracellular substances, and ultimately resulting in
impairment of vital bacterial activities [30]. Consequently, it is expected that polymers with higher
charge densities resulted in an improved antimicrobial activity. Indeed, there are successful studies
related to PVA/CHI systems, which show adequate cell viability, non-toxicity, and suitable properties
which can be tailored for prospective uses in tissue engineering [19,29,31,32].
Despite the remarkable properties that the individual polymers evince, reinforce such properties
by adding an antibiotic might be deemed as an interesting approach for treating bacteria colonization.
In this matter, sodium ampicillin (AMP) is used to treating urinary infections, salmonellosis, Listeria
meningitis, and periodontitis among others which implies that AMP has a broad target for both
Gram-positive and some Gram-negative bacteria [17].
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For all the aforementioned reasons, this work deals with the synthesis and characterization
of a BAPS as well as the evaluation of their antibacterial activity against Staphylococcus aureus and
Escherichia coli.
2. Results and Discussion
2.1. Fourier Transform Infrared (FTIR)
Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) spectra of the assessed
samples are shown in Figure 1. Pristine PVA (Figure 1A(a)) displays a large band observed between
3550 and 3200 cm−1, which is linked to the stretching O–H from the intermolecular and intramolecular
hydrogen bonds [33–36]. The band located at 2914 arises from saturated C–H stretching, whereas the
band at 1423 cm−1 is related to –CH2– bending [37]. An absence of a signal in the region of 1700 cm−1
indicates that only a small amount of acetate groups can be present in the polymer chain as the used
PVA is highly hydrolyzed. Two peaks at 1659 and 1572 cm−1 may be associated with conjugated diones
or single carbonyls in a conjugation with C=C double bonds in a solid state, where peaks over 1700 cm−1
are not manifested [38]. The peak at 1155 cm−1 is connected to C–O stretching modes and a strong
dependency of its intensity on crystallinity degree of the solid PVA material was observed [39,40]. Other
authors [41,42] connect this band with C–O–C in ether bridges, and crosslinking of PVA is deduced
from the increase in absorbance at this wavenumber. The band centered at 1330 cm−1 may surge from
combination frequencies of CH and OH [43]. A strong peak located at 1060–1030 cm−1 is assigned
for a stretching C–O in a C–O–H group [41] but the band is shifted to 1096 cm−1 as a consequence of
interactions with unsaturated bonds [37]. The band assigned to CH2 rocking is located at 917 cm−1
whereas the signal at 854 cm−1 relies on C–O stretching [40].
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stretching occurred in the pyranose ring are located at 2920, 2880, 1430, 1320, 1275 and 
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Figure 1. FTIR spectra for BAPS. (A). Polymers with and without lactic acid and glutaraldehyde (ADD):
(a) PVA; (b) PVA/ADD; (c) CHI; (d) CHI/ADD. (B) PVA blends: (a) PVA/AMP 0.3%; (b) PVA/AMP
1%; (c) PVA/ADD/AMP 0.3%; (d) PVA/ADD/AMP 1.0%; (C) CHI blends: (a) CHI/AMP 0.3%; (b)
CHI/AMP 1.0%; (c) CHI/ADD/AMP 0.3%; (d) CHI/ADD/AMP 1.0%; (D) PVA/CHI blends: (a)
PVA/CHI/ADD/AMP 0.3%; (b) PVA/CHI/ADD/AMP 1.0%.
The FTIR spectrum for CHI exhibits a broad signal centered at 3348 cm−1 corresponding
to -OH functional groups and -NH group stretching vibrations. The symmetric and asymmetric
–CH2– stretching occurred in the pyranose ring are located at 2920, 2880, 1430, 1320, 1275 and
1245 cm−1 [32,44,45]. The bands located at 1650, 1586 cm−1, and 1322 cm−1 are associated with
amide I, amide II, and amide III respectively as well as the saccharine-related signals at 1155 and
900 cm−1 [32,46–49]. The peak at 1030 and 080 cm−1 indicate the C–O stretching vibration.
The addition of lactic acid (LA) as a plasticizer, and glutaraldehyde (GLU) as a crosslinker
(hereinafter as ADD) does not alter significantly the spectra (Figure 1A(a,b)). A growth of OH peaks
is a consequence of the presence of LA. The C=O band at approximately 1720 c −1 may denote that
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the aldehyde groups of GA did not completely react with the -OH groups of the PVA chain or the
contribution of remaining acetate groups of the PVA structure. In addition, the C–O stretching at
1088 cm−1 in pure PVA is replaced by a broader absorption band located between 1000 and 1140 cm−1,
which can be attributed to the ether (C–O) and the acetal ring (C–O–C) bands formed by the crosslinking
reaction of PVA with GA. It can be assumed that GA has acted as a chemical crosslinker among PVA
polymer chains [50]. By comparing CHI and CHI/ADD (Figure 1A(c,d)), a minor rise in the hydroxyl
groups signal is evident. Nonetheless, the combination of both GLU and LA has contradictory effects;
on one side, the crosslinker diminished the hydroxyl groups, but on the other, the plasticizer increased
them. For that reason, there is no clear tendency depicted in the spectra. An increase of the signal for
the imine bands as well as a drop on the amine are caused by the nucleophilic addition of the amine
from CHI with the aldehyde [31].
AMP shows an absorption peak in the region of 1730–1720 cm−1 (Figure 1B–D), which is caused
by C=O β-lactam stretching. The peaks at 1664 and 1560 cm−1 belong to C=O amide stretching and
-NH amide groups respectively [51]. By virtue of no other modifications in the spectra, it is plausible
to infer that no chemical interactions are occurring between PVA and CHI with AMP, which might
imply that the antibiotic can be released from the matrix and even that the structure does not suffer
significant modifications and no alterations on the antibacterial activity of AMP whatsoever. The same
features are evidenced in the spectra for CHI/ADD/AMP as well as PVA/CHI/ADD/AMP.
Blends of PVA/CHI show two bands around 1640 and 1560 cm−1, which are connected to
symmetric stretching and bending of acetamide groups, respectively. The change in the characteristic
shape of the CHI spectra, as well as the shifting of peak to a lower frequency range on account of
hydrogen bonding between -OH of PVA and -OH or -NH2 of chitosan were observed in the blended
films [52]. These results suggested the formation of hydrogen bonds between the CHI and PVA
molecules [53]. Special features are exhibited for the BAPS (Figure 1D). By comparing the CHI
spectrum with that obtained for the BAPS, an increase of the signal for the imine peak as well as a drop
on the amine signal caused by the nucleophilic addition of the amine from CHI with the aldehyde
(crosslinking reaction with GLU) are presented [31]. Furthermore, a carboxylic acid dimer, which is
manifested in the region of 1700–1725 cm−1 are originated from the acetic acid used for dissolving CHI
and the absorption at 3300–3250 cm−1 related to -OH and -NH stretching vibrations broadened and
shifted to a lower wavenumber suggests the formation of hydrogen bonds between CHI and PVA [54].
2.2. Scanning Electron Microscopy (SEM)
Figure 2 shows the surface and cross section of scanning electron microscopy (SEM) images of
PVA/ADD/AMP, CHI/ADD/AMP and PVA/CHI/ADD. No obvious agglomeration particles were
observed, suggesting well-dispersed components as well as a homogeneous structure with no phase
separation. The surface anomalies may be probably accounted for manipulation or storage; likewise,
samples based on CHI possess wavy areas, which may be ascribed to solvent evaporation.
With regard to the cross-section images, they depict that all of the specimens have gone through
a homogeneous and effective mixing process since there are no special moieties in the sample and
they look considerably uniform. It is well-established that LA plasticizes the material and its presence
increases the toughness. On the contrary, GLU promotes brittleness. The SEM pictures are in total
correspondence with the obtained results from the FTIR spectra where there is a defined intermolecular
interaction between PVA and CHI; however, this mentioned interaction is not a physical barrier, which
could interfere with the release of AMP from the obtained films.
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2.3. Differential Scanning Calorimetry (DSC)
The thermograms for the prepared samples are depicted in Figure 3 and they correspond to the
first heating scan. The glass transition temperature (Tg) (72 ◦C) and melting point (Tm) (218 ◦C) for PVA
(Figure 3A(a)) have been reported in several publications and the results are in a good concordance
with those obtained in the performed experiment [55,56]. The presence of LA and GLU influence
the thermal features of the samples. Thus, the plasticizer reduces the number of lattices, causing a
decrease in the endothermic peak compared with pristine PVA, whereas the low concentration of the
crosslinker in comparison to LA produces a partial grafted hydroxyl group of PVA [1]. As a result,
blends of PVA/ADD melted at lower temperatures (Figure 3A(d)).
The thermograms exhibit a second endothermic peak, which is ascribed to the melting of the other
minor crystalline phases. Simultaneously, no evidence of transitions related to AMP is manifested
in the thermograms due to its low concentration in the samples, and because the reported Tm of the
antibiotic (220 ◦C) [57,58] is hidden by the endothermic manifestation for PVA.
CHI shows an endothermic transition between 100–120 ◦C that might be attributed to the
evaporation of residual water [44] whereas a sharp peak at 180 ◦C does not correspond to Tm since
a recrystallization peak neither appears in the second cooling nor in the second heating scan [59].
The effects of ADD are visible in the thermograms as the amine functional groups of CHI are more
reactive to GLU than the hydroxyl groups of PVA [32,60]. Therefore, a rise in the crystalline region
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is manifested. Furthermore, the crystallinity decreases as the crosslinking degree by GLU increases,
since crosslinks between two CHI units or pendant GLU with one aldehyde free may constitute an
obstacle to chitosan molecule packing. As in the case of PVA samples, the Tm of AMP is not visible
because of peak overlapping. BAPS exhibit endothermic peaks which started from room temperature
and lasted at around 150 ◦C. This peak can be attributed to the presence of water molecules inside the
PVA and CHI structure including tightly bound water which is released at about 100 ◦C, and the free
loosely bound water, which exited at around 150 ◦C [61]. A sharp endothermic peak near to 200 ◦C
belongs to Tm of the blend since the endothermic peaks for PVA shifted towards lower temperatures
by the presence of CHI [53]. The reduction of Tm indicates a good miscibility of the polymers that
affects the crystallization process of PVA. This drop of either the crystallization or melting temperature
is considered as a measure of the blend compatibility [62].
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Figure 3. Thermogram for BAPS. (A). Polymers with and without ADD: (a) CHI; (b) CHI/ADD; (c)
PVA; (d) PVA/ADD; (B) PVA blends: (a) PVA/AMP 0.3%; (b) PVA/AMP 1%; (c) PVA/ADD/AMP
0.3%; (d) PVA/ADD/AMP 1.0%; (C) CHI blends: (a) CHI/AMP 0.3%; (b) CHI/AMP 1.0%; (c)
CHI/ADD/AMP 0.3%; (d) CHI/ADD/AMP 1.0%; (D) PVA/CHI blends: (a) PVA/CHI/ADD/AMP
0.3%; (b) PVA/CHI/ADD/AMP 1.0%.
2.4. Surface Wettability
In order to estimate the extent of hydrophilicity, contact angle measurements were carried out.
The co tact angle values of deionized water (θw), ethyle e glycol (θe), and diiodomethane (θd) are
reported in Table 1. Fig re 4 exhibits the images taken for BAPS. S lid surfaces may be classified into
two basic groups, hydrophilic (wettable with water a d high surface energy) and hydrophobic (not
wetta le with water and low surface energy). Since a solid surface may be considered wettable if the
contact angle is less than 90◦, all the samples are in fact wettable. However, it is more reasonable to
describe them as hydrophilic. The hydrophilicity of PVA stems from the hydrogen bonding between
free -OH groups and water molecules. This feature might be reduced as t e cr sslinker reduces the
availability of hydroxyl groups [50] as well as for the crystallinity (see DSC results).
In the case of CHI, the hydroxyl and amino groups increase the formed hydrogen bonding
and, therefore, the material exhibits hydrophilic features. The plasticizer interrupts the sequence
of hydrogen bonding, the intermolecular forces are affected reducing the availability of hydrophilic
groups, a d the material increases the contact angle. It may be observed that the samples with ADD
are relatively more hydrophobic, having water contact angles above 50◦. However, it seems that after
some amount of AMP the hydrop ilicity diminished again as a consequence of the intermolecular
attractions that occur between the polymer and the antibiotic. Within this context, it is relevant to point
out that a hydrophilic surface would offer a better contact with biological species and enhance the
antimicrobial efficacy of the active ingredients [63]. It might explain that samples with ADD exhibit
better antibacterial activity for E. coli than specimens that did not contain the plasticizer and crosslinker.
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Table 1. Contact angle values for the prepared materials.
Description Contact Angle (
◦)
Water Ethylene glycol Diiodomethane
PVA <10 * <10 34.93 ± 5.33
CHI <10 * <10 45.33 ± 1.71
PVA/AMP 0.3% <10 * *** 35.24 ± 4.97
PVA/AMP 1.0% <10 * *** 41.46 ± 3.82
CHI/AMP 0.3% <10 * 55.76 ± 4.75 45.55 ± 3.34
CHI/AMP 1.0% <10 * 47.73 ± 6.54 45.56 ± 3.02
PVA/ADD/AMP 0.3% 61.14 ± 4.13 ** *** 22.94 ± 2.00
PVA/ADD/AMP 1.0% 43.12 ± 1.62 ** *** 34.35 ± 2.59
CHI/ADD/AMP 0.3% <10 * *** 45.51 ± 3.45
CHI/ADD/AMP 1.0% <10 * *** 44.24 ± 5.69
PVA/CHI/ADD/AMP 0.3% 62.43 ± 3.82 ** 44.36 ± 2.65 45.06 ± 2.61
PVA/CHI/ADD/AMP 1.0% 53.91 ± 2.67 ** 43.22 ± 1.93 51.58 ± 3.88
* In these cases the samples are hydrophilic and the surface got wet very quickly. ** Although the samples have a
water contact angle, the specimens got swollen in approximately 5 s. *** It reacted with the solvent.
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Figure 4. Images for contact angle measurements. (A) PVA/CHI/ / P 0.3 (ethylene glycol);
(B) PVA/C I/ /AMP 0.3% (diiodomethane); (C) PVA/CHI/ADD/AMP 1.0% (ethylene glycol)
(D). PVA/CHI/ADD/AMP 1.0% (diiodomethane).
The presen e of ADD has a higher impact on PVA than on CHI. As can be seen, a rise in the
contact angle values is reported for samples containing PVA, including BAPS. It could indicate that the
interactions between ADD and PVA are more effective in comparison to CHI.
2.5. Microbiological Testing
The method for evaluating the antibacterial activity w s a agar diffusion test. The obtain d
results are reported in Table 2 and the inhibition halo of the tested materials are presented in Figure 5.
As it can be expected, PVA did not show antibacterial activity whereas CHI requires a deeper
sight. The antibacterial properties of this natural polymer depend on the molecular weight and
generally show stronger bactericidal effects for Gram-positive than Gram-negative bacteria [64].
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Furthermore, CHI is prepared in acetic acid, a substance which has antimicrobial activity, and bacteria
in different growth stages have different sensitivity to CHI [65]. Indeed, it has been demonstrated
that its antibacterial activity depends on the strain examined and on its growth phase, besides the
concentration, degree of deacetylation, pH, temperature, and medium composition [66]. Then, it
is plausible to affirm that the prepared samples of CHI do not have the appropriate conditions to
be effective against the tested bacteria, although the presence of AMP might enhance its inherent
bactericidal feature.
Table 2. Agar diffusion test of the studied sample against Staphylococcus aureus and Escherichia coli.
Sample Inhibition Zone (mm)Staphylococcus aureus
Inhibition Zone (mm)
Escherichia coli
PVA - -
CHI - -
PVA/AMP 0.3% 2.34 ± 0.69 -
PVA/AMP 1.0% 3.54 ± 0.60 1.26 ± 0.05
* CHI/AMP 0.3% 3.26 ± 0.87 -
* CHI/AMP 1.0% 4.36 ± 0.35 -
PVA/ADD/AMP 0.3% - 1.27 ± 0.17
PVA/ADD/AMP 1.0% 1.30 ± 0.17 1.13 ± 0.05
* CHI/ADD/AMP 0.3% 3.61 ± 0.31 1.16 ± 0.21
* CHI/ADD/AMP 1.0% 4.18 ± 0.21 1.10 ± 0.16
* PVA/CHI/ADD/AMP 0.3% 1.18 ± 0.04 -
* PVA/CHI/ADD/AMP 1.0% 1.20 ± 0.10 -
* ANOVA test showed that CHI was the unique component which its significance was higher than ρ < 0.05.
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Fig re 5. Inhibition zone for BAPS. (A,B) PVA/AMP 1.0% against Staphylococcus aureus and
Escherichia coli. (C,D) PVA/ADD/AMP 1.0% against Staphylococcus aureus and Escherichia coli. (E,F)
CHI/ADD/AMP 1.0% against Staphylococcus aureus and Escherichia coli. (G) PVA/CHI/ADD/AMP
0.3% against Staphylococcus aureus (H) PVA/CHI/ADD/AMP 1.0% against Staphylococcus aureus.
By comparing the presence of AMP in CHI and PVA against Staphylococcus aureus it is remarkable
that at the same concentration of the antibiotic, the antibacterial act vity of CHI is higher than PVA
which migh indicat that the bacte ic dal or bacteriostatic properties of CHI are reinforced by the
presence of AMP. The combina ion of polymers with ADD increases th po itive charges for CHI,
which a responsible for its bactericidal features [67,68]. Therefore, CHI/ADD presents highe
antimicrobi l activity than PVA/ADD. It m y be also a consequence of synergic effects; for instance,
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this phenomenon is typically observed with phytochemicals, where certain molecules elicit greater
influence as a group than as individual entities [67–69].
Three mechanisms have been proposed as an explanation for the antimicrobial properties of
CHI. In the first one, the positive charges presented in the polymeric chain of CHI, on account of
its amino group, interact with the negative charges from the residues of macromolecules in the
membranes of microbial cells, interfering with a nutrient exchange between the exterior and interior of
the cell. These charges may also compete with calcium for the electronegative sites in the membrane,
compromising its integrity and causing a release of intracellular material and cellular death. The second
mechanism states that CHI acts as a chelating agent, creating compounds from traces of metals essential
to the cell, while the third mechanism asserts that CHI of low molecular weight is capable of entering
into the nucleus of the cell, interacting with DNA, interfering with messenger RNA synthesis, affecting
the synthesis of proteins, and inhibiting the action of various enzymes [18].
The molecular weight and the presence of ADD can alter the antimicrobial activity of CHI [24].
Nevertheless, the obtained results suggest that crosslinked CHI did not alter significantly their
antibacterial capability. Furthermore, highly deacetylated CHI (75–85% in this research) exhibits
a stronger antimicrobial activity than those with a higher proportion of acetylated amino groups, due
to an increased solubility and a higher charge density [70].
It is relevant to emphasize that as far as inhibition is concerned, the highest amount of AMP
exhibits the most effective antibacterial activity indicating that the antibiotic is released from the
polymer matrix and it retains its antibacterial capacity. However, it is remarkably important that the
prepared BAPS disclosed moderate antibacterial activity against bacterial strains without adding an
extremely high concentration of antibiotic. In this matter, it has been established that AMP as a pure
drug exhibits a minimum inhibitory concentration (MIC) of 3.13 and 0.20 µg/mL against E. coli and
S. aureus strains [71]. For that reason, in samples with the same antibiotic concentration, the inhibition
halo is higher for S. aureus than for E. coli. In the present study, the concentration of AMP was in the
range of 30–100 µg/mL although it is plausible to infer that a minor amount of antibiotic is released
from the matrix. That amount is located primarily on the surface of the film while the rest remains in
the bulk, which can be delivered into the media once the sample dissolves as a consequence of the
interaction with the solvent. In the same way, the samples that were crosslinked are diluted to a lesser
extent, the antibiotic has a more complex pathway to get the exterior of the system. However, the effect
of the plasticizer (an increase of the free spaces of the molecules) allows the diffusion of water and a
greater amount of antibiotic can be released.
A difference in efficacy of Gram-positive and Gram-negative microorganism can be explained
by the variance in the structure of the bacterial cell wall. The Gram-positive cell wall has a thicker
peptidoglycan layer whereas the Gram-negative cell wall has one additional outer membrane [63].
That membrane impedes the action of the antibiotic. Although the results were consistent with the
features for CHI and PVA, it is necessary to explain that AMP was effective against E. coli in PVA but
not in CHI. E. coli cells are considered moderately hydrophilic whereas S. aureus cells exhibited more
hydrophobic characteristics [72]. In this matter, the hydrophilic characteristics of PVA promote the
liberation of AMP, which might interact ti a greater extent with this bacterium. On the contrary, CHI
presents a lower hydrophilicity in comparison to PVA, resulting in a more complicated mechanism
for AMP liberation. On the other hand, surface adherence is a natural tendency which is inherent
to bacteria and other microorganisms. It has four basic steps: adhesion, colonization, formation
and the subsequent bacterial biofilm growth. Biofilms act as a defense mechanism against external
agents; in consequence, the aim of any antimicrobial materials is preventing bacterial adhesion and
colonization, which are prerequisites to biofilm formation [73]. Therefore, any modification in the
hydrophilicity of the surface will have repercussions for biofilm formation and the bacterial are more
exposed to the action of the antibiotic. The use of ADD affected both PVA and CHI whether causing a
reduction in the concentration of amino groups [48,74], or a lower content of hydroxyl groups [1]. Yet,
interactions between the hydroxyl groups of PVA and the amino or hydroxyl groups of CHI might
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reduce the overall hydrophilicity of the system. Thus, the obtained results might be a consequence of
the action of the released AMP, the hydrophilicity of the system, and the smoothness of the surface
(see SEM images).
Two systems, PVA/CHI/ADD/AMP 0.3% and 1.0% did not reveal any inhibition over E. coli.
As it might be foreseen, the difference between the expected and the obtained results may be ascribed
to the fact that CHI hinders the adhesion of a Gram-positive strain but does not behave satisfactorily
against Gram-negative bacteria, which may explain why the inhibition on PVA substrates is slightly
better than on the CHI ones [75,76]. Moreover, the model of the wall of E. coli remains unsolved [77]
although it has been established that the mechanism of AMP activity affects the cell wall synthesis as
well as the acquisition of resistance of this microorganism against the mentioned antibiotic [78].
An ANOVA test shows that AMP reinforces the antibacterial activity of CHI, whereas PVA
and ADD reduce slightly that property. Nonetheless, PVA and ADD enhance the poor mechanical
properties of CHI and the combination of both consolidates the BAPS as a material with improved
biological and physical features.
2.6. Antibiotic Release Studies
The mean cumulative mass of AMP released from the studied samples into distilled water as a
function of elution time and the calculated constant of the Equation 1 are summarized in the Table 3.
Table 3. Release studies of AMP from the prepared samples.
% AMP CMAX (µg/g) −k× 10−3 (1/h) R2
PVA/AMP 0.3% 26.69 ± 0.94 43.1 0.90
PVA/AMP 1.0% 70.54 ± 0.71 53.8 0.90
CHI/AMP 0.3% 27.11 ± 0.85 45.5 0.90
CHI/AMP 1.0 % 75.90 ± 2.09 70.5 0.90
PVA/ADD/AMP 0.3% 27.13 ± 0.40 0.40 0.90
PVA/ADD/AMP 1.0% 75.60 ± 1.63 * 0.45 0.90
CHI/ADD/AMP 0.3% 27.12 ± 0.44 57.9 0.90
CHI/ADD/AMP 1.0% 73.00 ± 2.16 68.7 0.95
PVA/CHI/ADD/AMP 0.3% 78.28 ± 0.23 * 0.33 0.95
PVA/CHI/ADD/AMP 1.0% 78.74 ± 2.58 * 0.41 0.95
* These values were obtained after 24 h. The others after 6 h.
According to the obtained data, the release profiles of PVA, CHI, and CHI/ADD showed a higher
rate constant (k). These results might indicate that the elution of AMP from the systems occurred in
the first part of the experiment. Then, as it is shown in Figure 6A,B, the released antibiotic levels off its
concentration in the media, and after the third measurement no AMP was detected. These final results
are consistent with the antibacterial test as well as the surface wettability which it might be related to
high affinity to the polar media of the PVA, CHI and the β-lactamic antibiotic used in this study.
The relevant results from the antibiotic release profiles focused on the BAPS were compared to all
batches of samples and exhibited the smallest rate constant. In this matter of fact, the participation of
ADD in the systems is related to the controlled release of AMP from the BASP which corresponded to
the long-lasting antibacterial activity of the system. The results are concomitant with the antibacterial
activity as well as the water contact angle results, showing the crucial role of ADD in the BAPS system
likewise the synergic performance of the PVA and CHI. The stability of the samples could be also taken
as outstanding results, since it showed a fast swelling due to the presence of LA, allowing the entrance
of water molecules in the bulk. However, the crosslinked PVA causes a decrease in hydrophilicity, and
the sustainable activity of the AMP for longer periods of time from the BASP is achieved.
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3. Materials and Methods
Poly(vinyl alcohol) (PVA, Mw 130,000 g mol−1) with 99% hydrolysis, chitosan of low molecular
weight a d 75–85% deacetylation degree (CHI), and a 25% solution of glutaraldehyde (GLU)
were provided by Sigma Aldrich, Bogotá, Colombia. Lactic acid (LA) was purchased at Fermont
(Bogotá-Colombia), hydrochloric acid (HA) at Scharlau (Bogotá, Colombia), anhydrous ethylene glycol
(99.8%) and diiodomethane (99%) were purchased from Sigma Aldrich (Saint Louis, MO, USA), and
sodium ampicillin (AMP) was produced by Farmalógica, S.A. (Bogotá-Colombia) and donated to
this research by The Hospital Cardiovascular del Niño de Cundinamarca (Soacha, Colombia). All of the
reagents were used as they were received.
3.1. Sample Preparation
An aqueous solution of PVA at 1 wt.% was prepared by dissolving the polymer in distilled water
for 6 h at 80 ◦C under continuous magnetic stirring (ThermoScientific—SP131325Q, Shangai, China).
Thereupon, LA at 5 wt.%, HA at 1.2 wt.%, and GLU at 0.25% with respect to the total amount of the
polymer were added as plasticizer and crosslinker agents and the solution was stirred for 20 more min.
CHI was dissolved in acetic acid (0.5 M) at room temperature by the slow addition of the polymer to
the solvent under mild magnetic stirring (ThermoScientific—SP131325Q, Shangai, China) for getting a
1 wt.% solution. Then, GLU (0.25 wt.%), HA (1.2 wt.%), and LA (5 wt.%) related to the total amount of
the polymer were added as crosslinker and plasticizer agents. Blends of a 1:1 ratio of PVA and CHI
were prepared and stirred until a homogeneous appearance with and without ADD followed by the
addition of AMP (0 to 1 wt.%, related to the polymer). The solutions were stirred for 10 min and films
were obtained using the casting method pouring 0.5 mL per cm2 on plastic Petri dishes and the films
were allowed to dry at 37 ◦C for a week in a no-air circulating oven.
3.2. Fo rier Transform Infrared (FTIR)
FITR spectroscopy analysis was carried out on NICOLET 6700 FTIR spectrometer device (Thermo
scientific, Waltham, MA, USA) equipped with attenuated total reflectance (ATR) accessory utilizing
the Zn–Se crystal and software package OMNIC over the range of wavelengths from 4000 to 600 cm−1
at room temperature under a resolution of 4 cm−1. Each spectrum represents 64 co-added scans
referenced against an empty ATR cell spectrum.
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3.3. Scanning Electron Microscopy (SEM)
Micrographs of the prepared samples were taken by the scanning electron microscope Nova
NanoSEM 450 (FEI, Brno, Czech Republic) with a Schottky field emission electron source operated at
an acceleration voltage ranging from 200 V to 30 kV and a low-vacuum SED (LVD) detector. A coating
with a thin layer of gold was performed by a sputter coater SC 7640 (Quorum Technologies, Newhaven,
East Sussex, UK).
3.4. Differential Scanning Calorimetry (DSC)
Calorimetric measurements were carried out in a DSC 1 calorimeter, Mettler Toledo (Greifensee,
Zurich, Switzerland), under nitrogen flowing at a rate of 30 mL min−1. The specimens were pressed
in sealed aluminum pans. A heating cycle was performed in order to acquire the glass transition
temperature (Tg) and melting temperature (Tm). The samples were cooled down by nitrogen at an
exponentially decreasing rate. The heating of the cycle was performed from 25 to 250 ◦C at a rate of
20 ◦C/min. The Tg was determined as the midpoint temperature by standard extrapolation of the
linear part of DSC curves using Mettler-Toledo Stare software and the Tm as the maximum value of the
melting peak.
3.5. Surface Wettability
The wettability of the samples was evaluated by contact angle measurement. The sessile drop
method was employed for this purpose on a Surface Energy Evaluation (SEE) system equipped with
a CCD camera (Advex Instruments, Brno, Czech Republic). Deionized water, diiodomethane, and
anhydrous ethylene glycol were used as testing liquids at 22 ◦C and 60% relative humidity. The droplets
volume was set to 5 µL for all experiments. Every representative contact angle value was an average
of 5 independent measurements.
3.6. Microbiological Tests
The antibacterial properties of the films were assessed by using the agar diffusion test. Round
specimens (8 mm in diameter) were placed on the surface of an individual nutrient agar plate, where a
bacterial solution of chosen microorganisms had been swabbed uniformly (Staphylococcus aureus-ATCC
9144, and Escherichia coli- ATCC 11775). After 24 h incubation at 37 ◦C, the dimensions of the inhibition
zones were measured in four directions, and the average values were used to calculate the circle zone
inhibition area.
3.7. Antibiotic Release Studies
To measure the AMP release, round shaped samples (15 mm in diameter) were immersed into
10 mL distilled water at 37 ◦C with continuous shaking (100 rpm). After defined periods of time,
the samples were transferred into the fresh medium to reach perfect sink conditions. The released
AMP in the elutions was detected by UV-vis spectrophotometer (Thermo Scientific, Helios Gamma,
Waltham, MA, USA) at a wavelength of 210 nm. Calibration dependences of the absorbance (A)
on AMP concentration (CAMP in µg·L−1) for release in distilled water (A = 0.0528 CAMP + 0.0436,
R2 = 0.9984) were determined prior to the release investigation. Afterwards, the cumulative mass was
calculated. The measurements were performed by triplicate. The observed data of the cumulative mass
of the released AMP related to 1 g of the sample material were evaluated by using first-order kinetics
(Equation (1)) and regression processed by the least squared where CREL (µg/g) is the experimental
concentration of AMP that was released at time t, CMAX (µg/g), means the maximal theoretical
concentration of the AMP released from 1 g of the sample, and −k(h−1) represents the rate constant
i.e., time needed to reach CMAX.
CREL = CMAX × (1 − e−kt) (1)
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3.8. Statistical Analysis
Microbiological tests were performed in quintuplicate and the experimental values are reported
in form of average ± standard deviation. Results were statistically compared applying a multifactorial
analysis of variance (ANOVA) with p < 0.05 with SPSS software.
4. Conclusions
This contribution delved into the incorporation of sodium ampicillin to PVA/CHI system.
The studied-referred to herein as BAPS were uniform and stable with interesting antibacterial results.
It was observed throughout this study that the presence of AMP is different in each system, where
under the same concentration of the antibiotic, the antibacterial activity of CHI was higher than
PVA which might indicate that the bactericidal or bacteriostatic properties of CHI were reinforced by
synergic effects with AMP. Indeed, it is plausible to infer that AMP might be released from the polymer
matrix and the antibiotic keeps its antibacterial activity. The prepared BAPS endorse an interesting
breakthrough in the development of novel antimicrobial biomaterials potentially suitable for tissue
engineering applications, since the samples with only 0.3% of AMP showed effectiveness against both
Gram-positive and Gram-negative bacterial strains without adding a high antibiotic concentration.
Apart from the microbiological test, succinct spectroscopic, topographical and thermal
assessments have been made shedding light on the chemical and thermal variations which occur when
any of the starting material is added. Polymer science and material innovation is undeniably a path
towards creativity with eminent progress in the last years and with great challenges to overcome
and the bio-artificial polymeric systems appraise here are indeed a promising approach for tissue
engineering applications. Hence, the findings of this study open the door to more in-depth research
both from scientific and medical standpoints.
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